Experience
Medicis Pharmaceutical Corp.
Zydus Pharmaceuticals (USA) Inc.
Assisted in representing Medicis in Hatch-Waxman patent litigation concerning ANDA for generic version of Vanos®.
Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc., 3:16-cv-01565, D.N.J., Judges Bumb, Shipp, Arpert, Schneider
Medicis Pharmaceutical Corp. v. Taro Pharmaceuticals USA, Inc.
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. v. Apotex, Inc.
Medicis Pharmaceutical Corp.
Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc.
Valeant Pharmaceuticals NA, LLC
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
Otsuka Pharmaceutical Co.
Dow Pharmaceutical Sciences, Inc. v. Taro Pharmaceuticals U.S.A., Inc.
Dow Pharmaceutical Sciences, Inc.; Valeant
Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc.
Valeant; Salix; Progenics
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.